{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid246zxu6k63743z3qaxmy6gax2wkl7cfbjujrxayhjmeb2fjhuwu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mogpufyosrd2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifhjwk247zl4vroqj7yv5igmnp5vxx3jfiza3xbo5eqb4wm6lqbya"
    },
    "mimeType": "image/jpeg",
    "size": 123839
  },
  "path": "/news/2026-06-ada-orforglipron-beneficial-hba1c-diabetes.html",
  "publishedAt": "2026-06-16T17:00:07.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Orforglipron is beneficial for blood glucose control in individuals with type 2 diabetes using metformin or taking insulin glargine, according to two studies published online June 8 in The Lancet and the JAMA to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.",
  "title": "ADA: Orforglipron beneficial for reducing HbA1c in type 2 diabetes"
}